施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BMY 施贵宝

休市中 09-04 16:00:00 EDT

66.82

-1.27

-1.87%

盘后66.83

+0.01+0.01%

19:56 EDT

最高67.72	最低66.58	成交量482.54万
今开67.24	昨收68.09	日振幅1.68%
总市值1,360亿	流通市值1,358亿	总股本20.36亿
成交额3.23亿	换手率0.24%	流通股本20.32亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"施贵宝","latestPrice":66.82,"timestamp":1788552000000,"preClose":68.09,"halted":0,"volume":4825447,"hourTrading":{"tag":"盘后","latestPrice":66.83,"preClose":66.82,"latestTime":"19:56 EDT","volume":393539,"amount":26296834.5308,"timestamp":1788566161151,"change":0.01,"changeRate":0.00015,"amplitude":0.002781},"delay":0,"changeRate":-0.018651784402996183,"floatShares":2031646263,"shares":2035753027,"eps":4.542906,"marketStatus":"休市中","change":-1.27,"latestTime":"09-04 16:00:00 EDT","open":67.24,"high":67.72,"low":66.575,"amount":322722276.27475,"amplitude":0.016816,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.542906,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":-18475200000,"exchange":"NYSE","adjPreClose":68.09,"dividendRate":0.037595,"preHourTrading":{"tag":"盘前","latestPrice":67.34,"preClose":68.09,"latestTime":"09:29 EDT","volume":1367,"amount":92342.79113999999,"timestamp":1788528599947,"change":-0.75,"changeRate":-0.011015,"amplitude":0.0199},"postHourTrading":{"tag":"盘后","latestPrice":66.83,"preClose":66.82,"latestTime":"19:56 EDT","volume":393539,"amount":26296834.5308,"timestamp":1788566161151,"change":0.01,"changeRate":0.00015,"amplitude":0.002781},"volumeRatio":0.6153492212461453,"impliedVol":0.2657,"impliedVolPercentile":0.127},"requestUrl":"/m/hq/s/BMY","defaultTab":"news","newsList":[{"id":"1102122486","title":"施贵宝发言人：已主动暂停Zola-Cel项目临床数据审查","url":"https://stock-news.laohu8.com/highlight/detail?id=1102122486","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102122486?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:49","pubTimestamp":1788263380,"startTime":"0","endTime":"0","summary":"施贵宝公司发言人今日表示，公司已实施一项自愿性暂停措施，旨在全面审视其Zola-Cel项目所涉及的临床数据。据悉，此次暂停并非因任何已明确的安全信号而起，而是出于对现有资料进行更为细致、系统性复核的审慎考量。通过此举，施贵宝力图确保所有临床环节均符合最高标准，从而为后续决策奠定坚实基础。目前，相关审查工作已有序展开。市场观察人士正密切关注这一动态，期望公司能在完成评估后，为Zola-Cel疗法的未来发展提供更清晰的路径指引。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1670711123.USD","LU1868836591.USD","LU0306807586.USD","LU0432979614.USD","IE00B2B36J28.USD","LU0096364046.USD","LU1868836757.USD","LU1291159041.SGD","BK4007","BK4585","IE0009355771.USD","LU0267386448.USD","LU1236620834.HKD","BK4534","LU1983299246.USD","IE00BJJMRZ35.SGD","LU1868837136.USD","IHE","LU0237698245.USD","LU1261432733.SGD","LU2242646821.SGD","BK4588","LU2596442595.SGD","LU0225284248.USD","BK4532","LU0985481810.HKD","LU1074936037.SGD","BK4581","LU1093756325.SGD","LU0321505439.SGD","LU0114720955.EUR","LU1670710661.SGD","BK4559","BMY","IE00BFTCPJ56.SGD","LU2133065610.SGD","IE00BJT1NW94.SGD","LU1718418525.SGD","FTXH","LU0456855351.SGD","LU1032466523.USD","LU1430594728.SGD","IE0002141913.USD","IE00BSNM7G36.USD","LU1670710588.SGD","LU1585245621.USD","LU2242652126.USD","LU0321505868.SGD","LU1571399168.USD","LU1868836914.USD","LU0882574055.USD","LU1989771016.USD","LU1323610961.USD","LU0061475181.USD","LU0868494617.USD","LU1868837300.USD","LU2125154935.USD","LU2360032135.SGD","LU0225771236.USD","LU1093756168.USD","LU1236620750.USD","LU0306806265.USD","LU1670711040.USD","LU1883839398.USD","LU2125154778.USD","IE00BFXG1179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663044361","title":"五年持续获益！玛伐凯泰最长随访数据公布，进一步证实在oHCM中的长期疗效与安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=2663044361","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663044361?lang=zh_cn&edition=full","pubTime":"2026-08-30 18:09","pubTimestamp":1788084540,"startTime":"0","endTime":"0","summary":"\"EXPLORER-LTE 长达五年的研究数据表明，玛伐凯泰可为有症状的oHCM患者带来持续且具有临床意义的治疗获益。此次ESC大会公布的其他研究结果进一步支持了玛伐凯泰的疗效和安全性，并加深了我们对oHCM疾病影响的理解。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5035957_ZH35957_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5035957_ZH35957_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU0203347892.USD","LU1571399168.USD","LU0237698245.USD","IE00BJJMRZ35.SGD","IHE","IE00BFTCPJ56.SGD","LU0985481810.HKD","LU1670711123.USD","LU1718418525.SGD","LU0321505868.SGD","LU1585245621.USD","LU2242646821.SGD","BK4532","BK4533","BMY","FTXH","CMI","LU1093756168.USD","IE00B2B36J28.USD","HCM","BK4149","LU0267386448.USD","LU1868837136.USD","LU1291159041.SGD","IE00BJT1NW94.SGD","BK4531","LU1983299246.USD","LU0306806265.USD","LU0069063385.USD","LU1074936037.SGD","MADE","LU2463526074.USD","LU0882574055.USD","IE00BSNM7G36.USD","LU0306807586.USD","LU2133065610.SGD","LU0203345920.USD","IE000M9KFDE8.USD","LU2125154778.USD","LU1670711040.USD","BK4534","LU2125154935.USD","BK4567","LU0225284248.USD","LU0114720955.EUR","LU0154245756.USD","LU1032466523.USD","BK4007","LU0456855351.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138479318","title":"施贵宝发言人：Cellares合作的细胞穿梭系统未能达到商业化生产Breyanzi的必要标准","url":"https://stock-news.laohu8.com/highlight/detail?id=1138479318","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138479318?lang=zh_cn&edition=full","pubTime":"2026-08-25 23:36","pubTimestamp":1787672215,"startTime":"0","endTime":"0","summary":"施贵宝发言人近日表示，经评估，与Cellares合作的细胞穿梭系统被认定无法满足生产商业化Breyanzi所需的严格要求。因此，施贵宝选择终止该项合作评估，转而寻求其他可行的生产路径，以确保Breyanzi的供应稳定性和患者可及性不受影响。施贵宝方面未透露更多技术细节，但强调将继续致力于优化生产流程，并探索多元化的合作机会，以推动其肿瘤学管线的高效落地。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","IE00BFTCPJ56.SGD","BK4532","LU1074936037.SGD","LU0061475181.USD","LU1093756325.SGD","BK4581","IHE","LU1883839398.USD","LU0225771236.USD","BK4007","LU0267386448.USD","LU1868836914.USD","IE00BFXG1179.USD","FTXH","IE0002141913.USD","LU0096364046.USD","IE0009355771.USD","LU1868837136.USD","LU1983299246.USD","LU1430594728.SGD","LU1868836757.USD","LU1670710661.SGD","LU1868837300.USD","LU2596442595.SGD","LU2125154778.USD","BK4588","LU2360032135.SGD","LU1291159041.SGD","LU0882574055.USD","LU2242646821.SGD","LU0237698245.USD","LU1670711123.USD","LU0114720955.EUR","LU1261432733.SGD","LU0321505868.SGD","LU1585245621.USD","LU0321505439.SGD","LU0868494617.USD","LU1989771016.USD","LU2242652126.USD","LU2125154935.USD","BK4585","LU2133065610.SGD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","BK4559","IE00B2B36J28.USD","LU0225284248.USD","LU0306806265.USD","LU0456855351.SGD","BK4534","LU1670710588.SGD","LU1868836591.USD","LU1718418525.SGD","LU1093756168.USD","LU0432979614.USD","LU1571399168.USD","LU0306807586.USD","LU1670711040.USD","IE00BJJMRZ35.SGD","LU1323610961.USD","LU1032466523.USD","LU0985481810.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662154755","title":"百时美施贵宝发言人确认，已终止与Cellares的合作关系。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662154755","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662154755?lang=zh_cn&edition=full","pubTime":"2026-08-25 23:35","pubTimestamp":1787672120,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0225284248.USD","BK4581","LU0868494617.USD","IE00BSNM7G36.USD","LU1670710588.SGD","LU2125154935.USD","IE00BFTCPJ56.SGD","LU1670711123.USD","LU0456855351.SGD","LU1093756325.SGD","LU0114720955.EUR","LU1323610961.USD","IE0009355771.USD","LU1989771016.USD","IE00BJT1NW94.SGD","LU2360032135.SGD","BK4559","LU0061475181.USD","LU2242646821.SGD","BK4007","BK4585","IE00BFXG1179.USD","LU2133065610.SGD","LU2242652126.USD","LU0985481810.HKD","LU1868837136.USD","LU1718418525.SGD","LU1883839398.USD","LU1291159041.SGD","LU1261432733.SGD","LU1868836591.USD","LU1983299246.USD","LU1032466523.USD","LU1585245621.USD","LU1670711040.USD","LU0432979614.USD","LU0321505439.SGD","LU0237698245.USD","LU0267386448.USD","LU1093756168.USD","LU1868836914.USD","LU2125154778.USD","FTXH","IE00BJJMRZ35.SGD","LU2596442595.SGD","LU0225771236.USD","BMY","IHE","LU0096364046.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111103812","title":"异动解读｜施贵宝盘中上涨3.02%，制药板块全线走强叠加AI抗体研发合作提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1111103812","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111103812?lang=zh_cn&edition=full","pubTime":"2026-08-21 23:00","pubTimestamp":1787324442,"startTime":"0","endTime":"0","summary":"8月21日，施贵宝盘中上涨3.02%，报67.45美元/股，成交额1.58亿美元。消息面上，施贵宝近日宣布与Chai Discovery达成抗体研发合作协议，将利用Chai的AI分子折叠与设计模型加速药物发现进程，探索传统方法难以触及的靶点。同时，制药板块整体表现强劲，默沙东涨3.47%、辉瑞涨2.21%、礼来涨1.93%、强生涨1.51%，板块联动效应显著。施贵宝前一交易日曾随板块回调跌逾3%，当前反弹亦受到技术性修复推动。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"施贵宝上涨，AI抗体合作引爆制药板块","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124108304","title":"异动解读｜施贵宝盘中下跌3.03%，报65.565美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124108304","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124108304?lang=zh_cn&edition=full","pubTime":"2026-08-21 03:47","pubTimestamp":1787255247,"startTime":"0","endTime":"0","summary":"8月21日，施贵宝盘中下跌3.03%，报65.565美元/股，成交额4.24亿美元。施贵宝所在的制药行业整体承压，个股中，礼来跌2.7%，默沙东跌2.0%，强生跌2.01%，阿斯利康跌0.24%，Crinetics Pharmaceuticals持平。百时美施贵宝公司是一家全球性生物制药企业，专注于肿瘤学、血液学、免疫学、心血管和神经科学等领域创新药物的发现与开发，产品在全球范围内销售。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287974","title":"百时美施贵宝与Chai Discovery合作利用AI开发新疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287974","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660287974?lang=zh_cn&edition=full","pubTime":"2026-08-20 21:27","pubTimestamp":1787232474,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0882574055.USD","LU0456855351.SGD","AIPO","LU1868836757.USD","QTOC","LU1989771016.USD","VTHR","LU1261432733.SGD","LU1093756325.SGD","BK4534","LU2242646821.SGD","LU0868494617.USD","LU1868837136.USD","LU1571399168.USD","LU2133065610.SGD","LU1868836591.USD","AGIX","IE00BJJMRZ35.SGD","LU1291159041.SGD","IHE","LU2125154778.USD","LU0321505439.SGD","ARTY","IE00BFXG1179.USD","LU0306806265.USD","BK4007","LU2360032135.SGD","LU1670710661.SGD","LU1093756168.USD","LU1883839398.USD","LU1718418525.SGD","LU1032466523.USD","BK4588","LU1074936037.SGD","LU0321505868.SGD","LU1670711123.USD","FTXH","LU0432979614.USD","BK4585","BK4581","BK4532","LU0985481810.HKD","BMY","CHAT","LU1585245621.USD","LU2125154935.USD","LU2242652126.USD","LU0096364046.USD","IE00BSNM7G36.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660228241","title":"Chai Discovery与百时美施贵宝达成抗体研发合作协议，百时美施贵宝将使用Chai AI模型支持抗体发现。","url":"https://stock-news.laohu8.com/highlight/detail?id=2660228241","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660228241?lang=zh_cn&edition=full","pubTime":"2026-08-20 21:03","pubTimestamp":1787230989,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0321505868.SGD","LU0868494617.USD","LU0225284248.USD","LU1291159041.SGD","LU1868836757.USD","LU1585245621.USD","BK4532","LU1261432733.SGD","LU2242652126.USD","BK4588","IE00B2B36J28.USD","BMY","LU0321505439.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","AIPO","FTXH","LU0985481810.HKD","LU1989771016.USD","LU0225771236.USD","QTOC","LU1670711040.USD","LU1868836591.USD","LU2133065610.SGD","LU1868836914.USD","IE00BSNM7G36.USD","LU0306806265.USD","LU1868837300.USD","IE00BJT1NW94.SGD","LU2242646821.SGD","VTHR","IHE","LU0096364046.USD","IE00BFXG1179.USD","AGIX","LU2360032135.SGD","LU1670711123.USD","ARTY","LU2125154778.USD","LU2596442595.SGD","LU0882574055.USD","IE00BJJMRZ35.SGD","LU1074936037.SGD","LU1093756325.SGD","BK4534","LU1883839398.USD","LU0456855351.SGD","LU1093756168.USD","BK4007","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158253265","title":"异动解读｜施贵宝盘中上涨3.11%，Zenbexus获FDA加速批准叠加制药板块走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1158253265","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158253265?lang=zh_cn&edition=full","pubTime":"2026-08-19 21:52","pubTimestamp":1787147568,"startTime":"0","endTime":"0","summary":"8月19日，施贵宝盘中上涨3.11%，报68.1美元/股，成交额1.1亿美元。消息面上，FDA于8月14日授予施贵宝首款Celmod疗法Zenbexus联合达雷妥尤单抗及地塞米松的加速批准，用于治疗至少接受过一线治疗的多发性骨髓瘤成人患者。三期临床数据显示，Zenbexus组合方案的微小残留病灶阴性完全缓解率达41%，显著优于对照组的21%。当日制药板块整体表现强劲，默沙东涨10.37%、礼来涨4.61%、辉瑞涨3.23%，板块联动效应亦对施贵宝形成提振。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659219498","title":"施贵宝iberdomide获FDA批准用于治疗多发性骨髓瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2659219498","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659219498?lang=zh_cn&edition=full","pubTime":"2026-08-14 10:28","pubTimestamp":1786674495,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0882574055.USD","LU1868836757.USD","LU1989771016.USD","IE00BJT1NW94.SGD","LU1261432733.SGD","LU1093756325.SGD","BK4534","IE0009355771.USD","LU0237698245.USD","LU0868494617.USD","LU1868837136.USD","LU2133065610.SGD","IE0002141913.USD","LU1868836591.USD","IE00BJJMRZ35.SGD","LU1291159041.SGD","LABU","IHE","LU1430594728.SGD","LU2125154778.USD","IE00BFXG1179.USD","LU0306806265.USD","LU1670710661.SGD","LU1670710588.SGD","LU1093756168.USD","LU0267386448.USD","LU1718418525.SGD","LU1983299246.USD","BK4559","LU1032466523.USD","BK4588","LU1074936037.SGD","LU0306807586.USD","IE00BFTCPJ56.SGD","LU0321505868.SGD","FTXH","IE00B2B36J28.USD","LU0432979614.USD","LU0225771236.USD","LU1323610961.USD","LU0225284248.USD","LU1868836914.USD","BK4581","BMY","LU2125154935.USD","LU0061475181.USD","LU2242652126.USD","LU0096364046.USD","IE00BSNM7G36.USD","LU2360032135.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179303038","title":"美国FDA加速批准百时美施贵宝首款Celmod疗法Zenbexus™联合用药方案，用于多发性骨髓瘤首次复发患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1179303038","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179303038?lang=zh_cn&edition=full","pubTime":"2026-08-14 05:13","pubTimestamp":1786655593,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已正式授予加速批准，同意百时美施贵宝（Bristol Myers Squibb）旗下首款Celmod疗法——Zenbexus™，与达雷妥尤单抗、透明质酸酶-Fihj以及地塞米松联合组成Zdd方案，用于治疗多发性骨髓瘤患者。这一批准适用于从首次复发阶段起，即可启用该疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","LU2360032135.SGD","BK4534","LU1430594728.SGD","FTXH","LU2242652126.USD","IE0002141913.USD","LU1868836591.USD","IE00BFXG1179.USD","LU1670710661.SGD","LU0321505868.SGD","IE00BJT1NW94.SGD","LU1670711040.USD","LU2242646821.SGD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU1074936037.SGD","LU2125154935.USD","LU0456855351.SGD","LU0432979614.USD","IE0009355771.USD","LU1093756168.USD","LU1989771016.USD","BK4007","BK4585","LU0225771236.USD","IE00B2B36J28.USD","BMY","LU0237698245.USD","LU1291159041.SGD","LU1983299246.USD","LU1585245621.USD","LU0096364046.USD","LU2596442595.SGD","LU0985481810.HKD","LU0267386448.USD","LU1718418525.SGD","LU1868837300.USD","LU0306807586.USD","IE00BSNM7G36.USD","LU1032466523.USD","BK4588","LU0306806265.USD","LU1261432733.SGD","LU0114720955.EUR","LU0321505439.SGD","LU0882574055.USD","IE00BJJMRZ35.SGD","LU0225284248.USD","LU1571399168.USD","LU1670711123.USD","LU1868836757.USD","LU2125154778.USD","LU1883839398.USD","LU1670710588.SGD","BK4581","LU1093756325.SGD","BK4532","BK4559","LU1323610961.USD","LU2133065610.SGD","LU1868836914.USD","LU0061475181.USD","LU1868837136.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115777296","title":"FDA加速批准Iberdomide联合Daratumumab与透明质酸酶及地塞米松用于多发性骨髓瘤治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1115777296","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115777296?lang=zh_cn&edition=full","pubTime":"2026-08-14 04:13","pubTimestamp":1786652015,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已正式授予Iberdomide联合Daratumumab、透明质酸酶-Fihj以及地塞米松的加速批准，用于治疗多发性骨髓瘤。这一组合疗法为患者带来了新的治疗选择。其中，Iberdomide是施贵宝（Bristol-Myers Squibb）研发的一款创新药物。此次批准基于临床试验中展现出的显著疗效，标志着在对抗这一血液系统恶性肿瘤方面取得了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836591.USD","LU0868494617.USD","LU1670711123.USD","LU0321505868.SGD","LU1670711040.USD","LU1718418525.SGD","LU2133065610.SGD","BK4588","LU1032466523.USD","LU0225771236.USD","LU0985481810.HKD","LU1323610961.USD","LU0237698245.USD","LU1868837136.USD","BK4007","LU0306807586.USD","LU0432979614.USD","LU0267386448.USD","LU1585245621.USD","IE00BJT1NW94.SGD","LU1670710661.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU1868836914.USD","IE00BFXG1179.USD","LU1670710588.SGD","LU1983299246.USD","IE00BSNM7G36.USD","LU0306806265.USD","LU0061475181.USD","LU1868836757.USD","LU1989771016.USD","LU0114720955.EUR","FTXH","LU0321505439.SGD","LU0225284248.USD","IE00B2B36J28.USD","LU1093756325.SGD","BK4534","LU0096364046.USD","LU2242646821.SGD","BK4581","IE0009355771.USD","LU0882574055.USD","LU2125154778.USD","LU1430594728.SGD","LU2360032135.SGD","BK4559","IE0002141913.USD","LU2125154935.USD","LU1291159041.SGD","LU1571399168.USD","BK4585","LU2242652126.USD","BMY","LU0456855351.SGD","LU1883839398.USD","LU1261432733.SGD","LU1093756168.USD","LU2596442595.SGD","BK4532","IHE","LU1868837300.USD","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659301150","title":"Cytokinetics对百时美施贵宝提起专利侵权诉讼。","url":"https://stock-news.laohu8.com/highlight/detail?id=2659301150","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659301150?lang=zh_cn&edition=full","pubTime":"2026-08-13 21:31","pubTimestamp":1786627862,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LU1093756168.USD","LU2125154935.USD","IE00B2B36J28.USD","IHE","LU0306806265.USD","LU1291159041.SGD","LU1718418525.SGD","BK4534","IE00BJJMRZ35.SGD","LU1670711040.USD","LU0432979614.USD","LU0882574055.USD","LU0306807586.USD","LU2125154778.USD","LU1868837136.USD","BK4139","LU1585245621.USD","LU2242652126.USD","LU1989771016.USD","LU0114720955.EUR","LU1868836914.USD","LU1074936037.SGD","LU0267386448.USD","IE00BFXG1179.USD","LU0225284248.USD","BK4532","IE0009355771.USD","LU2133065610.SGD","LU0868494617.USD","LU0456855351.SGD","LU0225771236.USD","LU1670710661.SGD","IE00BSNM7G36.USD","BK4559","BMY","IE00BFTCPJ56.SGD","FTXH","LU2360032135.SGD","BK4505","LU2242646821.SGD","BK4588","IE0002141913.USD","LU1868836591.USD","IE00BJT1NW94.SGD","LU0096364046.USD","CYTK","LU2596442595.SGD","LU1430594728.SGD","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120034487","title":"Atrium Therapeutics 获资格：研发里程碑可高达13.5亿美元，商业里程碑达8.25亿美元，另享阶梯式版税","url":"https://stock-news.laohu8.com/highlight/detail?id=1120034487","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120034487?lang=zh_cn&edition=full","pubTime":"2026-08-13 20:03","pubTimestamp":1786622625,"startTime":"0","endTime":"0","summary":"Atrium Therapeutics 公司已具备获得里程碑付款的资格。具体来看，其研发里程碑款项总额最高可达13.5亿美元。与此同时，商业里程碑的潜在金额也相当可观，达到了8.25亿美元。此外，该公司还将有权收取阶梯式版税。这一系列激励措施，为这家生物技术公司注入了强劲的发展动力，也凸显了其候选药物的巨大商业潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","LU0456855351.SGD","BK4534","LU0267386448.USD","LU1983299246.USD","LU1868836757.USD","BK4588","IE00BJT1NW94.SGD","BK4007","LU0096364046.USD","LU1032466523.USD","LU1093756168.USD","IE00BSNM7G36.USD","LU1670711123.USD","IHE","LU1868837136.USD","BK4532","LU1670710588.SGD","LU1989771016.USD","LU0321505439.SGD","LU1585245621.USD","LU2242652126.USD","LU2125154935.USD","LU1323610961.USD","LU0882574055.USD","LU1670710661.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU1074936037.SGD","LU1291159041.SGD","IE00B2B36J28.USD","LU0225284248.USD","LU0868494617.USD","FTXH","LU0321505868.SGD","LU2242646821.SGD","LU0114720955.EUR","LU2133065610.SGD","BK4505","LU1430594728.SGD","BMY","LU0432979614.USD","IE0009355771.USD","LU0985481810.HKD","LU1868837300.USD","IE0002141913.USD","LU1718418525.SGD","LU1571399168.USD","LU1670711040.USD","LU1883839398.USD","LU0306806265.USD","LU0306807586.USD","LU2360032135.SGD","BK4581","LU1261432733.SGD","IE00BFXG1179.USD","RNA","BK4139","LU2125154778.USD","IE0009354923.USD","LU0237698245.USD","LU1868836914.USD","LU0061475181.USD","LU1093756325.SGD","LU1868836591.USD","LU2596442595.SGD","BK4585","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176688754","title":"Atrium Therapeutics 获施贵宝1500万美元里程碑付款，源于全球心血管合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1176688754","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176688754?lang=zh_cn&edition=full","pubTime":"2026-08-13 20:02","pubTimestamp":1786622555,"startTime":"0","endTime":"0","summary":"Atrium Therapeutics 宣布，已从百时美施贵宝（Bristol Myers Squibb）获得一笔1500万美元的里程碑付款，这笔款项是基于双方此前达成的全球心血管疾病合作项目所产生的。此次付款标志着双方合作在研发或临床推进方面取得了关键性进展，进一步巩固了这两家公司在心血管治疗领域的战略联盟。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","BK4007","FTXH","LU0432979614.USD","LU0456855351.SGD","LU1032466523.USD","LU1323610961.USD","LU0868494617.USD","LU1585245621.USD","LU1883839398.USD","LU1261432733.SGD","LU1074936037.SGD","IE00BFTCPJ56.SGD","LU1989771016.USD","LU0882574055.USD","LU0225284248.USD","LU2125154935.USD","BK4588","LU0237698245.USD","IE00BFXG1179.USD","BK4559","LU1868837300.USD","LU1868837136.USD","LU2242652126.USD","IE0002141913.USD","LU0114720955.EUR","BK4505","LU0985481810.HKD","LU1868836591.USD","RNA","LU0321505439.SGD","LU0267386448.USD","LU1670710661.SGD","LU0096364046.USD","LU2596442595.SGD","LU0225771236.USD","LU1571399168.USD","BK4139","BK4534","LU2133065610.SGD","LU1670711123.USD","LU1093756168.USD","LU1718418525.SGD","BK4532","LU0061475181.USD","IE00BJJMRZ35.SGD","IHE","LU1430594728.SGD","LU1983299246.USD","LU1868836914.USD","LU1868836757.USD","BK4581","LU2360032135.SGD","IE0009355771.USD","LU1670710588.SGD","LU0306806265.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU1093756325.SGD","BMY","LU2242646821.SGD","IE00BSNM7G36.USD","BK4585","LU2125154778.USD","LU1670711040.USD","LU1291159041.SGD","IE0009354923.USD","LU0306807586.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182050958","title":"Atrium Therapeutics（RNA）获施贵宝全额资助，未来开发与商业化活动全面启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1182050958","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182050958?lang=zh_cn&edition=full","pubTime":"2026-08-13 20:01","pubTimestamp":1786622485,"startTime":"0","endTime":"0","summary":"Atrium Therapeutics宣布，制药巨头Bristol Myers Squibb将为其后续所有开发及商业化活动提供全额资金支持。这一战略合作标志着Atrium Therapeutics在创新疗法领域迈出关键一步，同时彰显了施贵宝对RNA平台技术潜力的强烈信心。根据协议，施贵宝将承担从临床研究到市场推广的全链条成本，从而大幅降低Atrium Therapeutics的财务风险，并加速其候选药物的上市进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA","LU1868836591.USD","LU0868494617.USD","LU1670711123.USD","LU0321505868.SGD","LU1670711040.USD","LU1718418525.SGD","LU2133065610.SGD","BK4588","LU1032466523.USD","LU0225771236.USD","LU0985481810.HKD","LU1323610961.USD","LU0237698245.USD","LU1868837136.USD","BK4007","LU0306807586.USD","LU0432979614.USD","LU0267386448.USD","LU1585245621.USD","IE00BJT1NW94.SGD","LU1670710661.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU1868836914.USD","IE00BFXG1179.USD","LU1670710588.SGD","LU1983299246.USD","IE00BSNM7G36.USD","LU0306806265.USD","LU0061475181.USD","LU1868836757.USD","LU1989771016.USD","LU0114720955.EUR","FTXH","LU0321505439.SGD","LU0225284248.USD","IE00B2B36J28.USD","LU1093756325.SGD","BK4534","LU0096364046.USD","LU2242646821.SGD","BK4581","IE0009355771.USD","LU0882574055.USD","LU2125154778.USD","LU1430594728.SGD","LU2360032135.SGD","BK4559","BK4139","IE0002141913.USD","LU1074936037.SGD","LU2125154935.USD","BK4505","LU1291159041.SGD","LU1571399168.USD","BK4585","LU2242652126.USD","BMY","LU0456855351.SGD","LU1883839398.USD","LU1261432733.SGD","LU1093756168.USD","LU2596442595.SGD","BK4532","IHE","LU1868837300.USD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658194289","title":"黄仁勋5000亿融资“撕裂市场”：资管巨头狂欢，科技股两日连跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2658194289","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658194289?lang=zh_cn&edition=full","pubTime":"2026-08-12 08:45","pubTimestamp":1786495546,"startTime":"0","endTime":"0","summary":"市场将这一融资安排解读为对私募信贷和另类投资的直接利好——庞大的资金管道意味着管理费收入的长期增长前景，KKR、阿波罗等另类资管巨头股价大涨3%至7%，但大型科技股连续承压。这一分化折射出深层隐忧：英伟达亲自为客户找融资，究竟是需求强劲还是需求需靠融资\"创造\"？","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3779236","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0724617625.USD","LU2361045086.USD","LU2063271972.USD","BK4127","LU0444973449.USD","LU1074936037.SGD","LU2237443549.SGD","BK4548","LU1674673691.USD","IE00BK4W5L77.USD","LU1804176565.USD","LU0320765489.SGD","LU1951198990.SGD","IE0004445239.USD","THMR","LU2286300806.USD","LU0557290698.USD","LU2360032135.SGD","LU1868837300.USD","LU1037948897.HKD","LU0225283273.USD","LU1670756490.USD","IE0004445015.USD","LU0170899867.USD","LU2637965513.SGD","LU2750360997.AUD","TYLG","LU0323240290.USD","LU0158827781.USD","07388","LU0175139822.USD","LU0048573561.USD","LU0395794307.EUR","LU2458330243.SGD","IE00B19Z3581.USD","LU1145028129.USD","LU0689472784.USD","LU2242650005.HKD","LU1861127337.USD","SPTE","LU0323239441.USD","LU1670628061.USD","LU0211328371.USD","IE0002141913.USD","LU2294711713.HKD","HK0000320264.USD","LU0823421333.USD","LU1720051017.SGD","FTXH","3NVD.UK","LU2168564149.EUR","LU2237957902.USD","NVD3.UK","IE00BKVL7J92.USD","LU2326559502.SGD","CHAT","LU0289960550.SGD","LU0077335932.USD","LU0861579265.USD","SGXZ80539844.SGD","LU0787776722.HKD","LU2592432038.USD","IE00B4YYXB79.USD","LU0057025933.USD","LU1935043023.USD","LU1868836757.USD","IE00B19Z9505.USD","HK0000819398.USD","LU1861220033.SGD","LU0466842654.USD","LU1989764664.SGD","SG9999001424.SGD","LU0107464264.USD","LU1923623000.USD","LU1852331112.SGD","IE00BDCRKT87.USD","LU0342679015.USD","LU0957808578.USD","LU2322448791.USD","LU0106831901.USD","CLSE","LU0203202063.USD","IE00B7KXQ091.USD","IE00BFSS7M15.SGD","LU1815333072.USD","LU0980610538.SGD","LU3102509885.SGD","BK4567","LU1548497426.USD","LU1642822529.SGD","IE00BFSS8Q28.SGD","LU1988902786.USD","LU2279689827.SGD","LU2456880835.USD","IE00BN29S564.USD","NULC","SG9999015341.SGD","IE00BKDWB100.SGD","LU1894683348.USD","LU0238689110.USD","BK4551","IE0004091025.USD","LU0432979614.USD","LU1599440770.SGD","LU2242646821.SGD","LU2347655073.USD","BK4135","SG9999015945.SGD","LU2077746001.SGD","IE0004086264.USD","LU1032466523.USD","APO","IE00B19Z8W00.USD","LU0081259029.USD","LU0979878070.USD","LU1732800096.USD","LU2462157665.USD","LU1429558221.USD","LU0511384066.AUD","LU0215105999.USD","LU0823421416.USD","LU1242518857.USD","LU1571399168.USD","LU0528227936.USD","IE00BN8TJ469.HKD","IE00BLSP4239.USD","LU1923622614.USD","BK4533","LU0742537680.HKD","LU2092937148.SGD","IE00B3QW5Z07.USD","LU0347712357.USD","LU2360106780.USD","LU2463028550.USD","LU1791710400.SGD","LU2125154778.USD","SG9999014575.USD","LU2168564222.USD","AIFD","LU0965509283.SGD","LU1366333091.USD","LU0444971666.USD","LU1037948541.HKD","IE00BJTD4V19.USD","LU1035775433.USD","ROM","LU0642271901.SGD","SMHX","LU0472753341.HKD","LU2954938101.SGD","LU0708994859.HKD","LU2394011477.USD","FAI","LU0276348264.USD","LU0306807586.USD","IE00BMPRXN33.USD","LU2125909247.SGD","LU0949170772.SGD","LU2065171311.SGD","VT","LU0211327993.USD","LU1670711123.USD","BK4543","IE00BMPRXQ63.HKD","LU1778281490.HKD","LU1316542783.SGD","BX","LU1645745479.HKD","BK4587","LU1242518931.SGD","LU1202635105.USD","GSX","LU2433249047.HKD","BK4579","LU1670710661.SGD","IE00B19Z3B42.SGD","LU2168564495.EUR","SGXZ99366536.SGD","LU2089985449.USD","IE0034235188.USD","LU2417539215.USD","IE00BWXC8680.SGD","IE00BQXX3F31.USD","LU1430594728.SGD","LU1914381329.SGD","SG9999014898.SGD","LU0011850046.USD","LU2347655156.SGD","IE00BJTD4N35.SGD","IE000ITXATA3.USD","IE00BGHQF631.EUR","LU0788109477.HKD","LU2087625088.SGD","LU2458330169.SGD","LU2602419157.SGD","LU2381873111.SGD","IE00B3M56506.USD","LU1839511570.USD","LU0719512351.SGD","LU0053666078.USD","LU0128525929.USD","LU0965508806.USD","LU2237438978.USD","LU0640476718.USD","LU1712237335.SGD","SHOC","IE00BKPKM429.USD","USXF","SG9999004303.SGD","BMY","LU0096364046.USD","SNVD.UK","LU1883839398.USD","LU2750360641.GBP","TTEQ","LU2108987350.USD","LU1201861249.SGD","LU2106854487.HKD","LU0306806265.USD","LU0868494708.USD","BK4504","LU1814569148.SGD","LU0820562030.AUD","LU2430703251.USD","LU0738911758.USD","IETC","BK4581","LU1119994496.HKD","BK4588","AGOX","ABFL","LU1791807156.HKD","NVDA","IE0034235303.USD","SGXZ51526630.SGD","LU2265009873.SGD","LU1674673428.USD","LU2462591350.SGD","GS","LU1935042488.USD","LU1366192091.USD","LU0310800379.SGD","LU0251142724.SGD","LU0882574139.USD","LU0345769631.USD","BK4007","LU1992135399.USD","LU2271345857.HKD","LU2237443895.HKD","LU1093756168.USD","LU1868836591.USD","IE00B5949003.HKD","LU1989764748.USD","LU2361044949.HKD","LU2247934214.USD","NVII","BK4608","LU2264538146.SGD","IE00BD6J9T35.USD","LU1035773651.USD","LU1623119135.USD","LU2028103732.USD","NVDY","LU2065170008.USD","LU1481011671.HKD","BK4585","LU2473716301.USD","SG9999015952.SGD","PSP","IE00BQXX3C00.GBP","LU0225771236.USD","LU0683600562.USD","SG9999002224.SGD","LU0265550359.USD","LU1069344957.HKD","LU0096362180.USD","LU0289961442.SGD","LU0198837287.USD","BK4554","LU0056508442.USD","LU0957791311.USD","LU0912757837.SGD","LU0256863811.USD","LU0345768740.USD","LU0820561909.HKD","LU1496350502.SGD","NVDS.UK","NVIW.SI","LU1935042991.SGD","LU0772969993.USD","AIPI","ARTY","LU1509826696.USD","SG9999015358.SGD","LU1232071149.USD","LU1244550577.SGD","LU0082616367.USD","IE00BFTCPJ56.SGD","IE00BZ199S13.USD","LU0006306889.USD","LU2756315664.SGD","SG9999014567.USD","SOXY","LU0079474960.USD","LU0114720955.EUR","LU0786609619.USD","LU1934455277.USD","IE00BJJMRZ35.SGD","LU1244550221.USD","BK4527","LU2237957811.SGD","LU1691799644.USD","LU0251132253.USD","LU1803068979.SGD","LU2133065610.SGD","LU0661504455.SGD","LU0234570918.USD","LU0316494557.USD","FDTX","CMAG","LU2491049909.HKD","LU0289739343.SGD","BLK","IE000KEQY171.SGD","LU0237698245.USD","AAUM","LU0094547139.USD","LU1153585028.USD","LU0321505868.SGD","LU0672654240.SGD","HK0000304797.USD","LU0061475181.USD","LU0097036916.USD","LU2213496289.HKD","LU2505996681.GBP","BK4612","SNPE","LU2083900584.USD","IE0009355771.USD","LU0882574055.USD","LU0390134368.USD","NVDB","LU1979441026.SGD","NVDO","IE00BVYPNV92.GBP","IE00B19Z8X17.USD","LU0476273544.USD","LU1291159041.SGD","LU0106261372.USD","LU1280957306.USD","SGXZ31699556.SGD","LU1670710588.SGD","HK0000914660.USD","IE0009G5SDU7.USD","IE00B3PB1722.GBP","LU0323591593.USD","LU0061474705.USD","LU1983260115.SGD","LU2471134523.USD","LU0965509010.AUD","IE00BJT1NW94.SGD","LU0308772762.SGD","IE00B3SWFQ91.USD","LU0069063385.USD","LU0964807845.USD","LU1066053197.SGD","IE00BHPRN162.USD","NVDL","LU1323610961.USD","IE0002270589.USD","LU0553294199.USD","LU2430703178.SGD","LU2746668461.USD","IE000W1ABFV2.USD","LU1699723380.USD","LU1880398554.USD","LU0210536198.USD","LU2896262040.SGD","LU2272731600.USD","LU2403377893.USD","HK0000914686.HKD","LU2461242641.AUD","LU0274383776.USD","SG9999014559.SGD","SG9999002232.USD","LU1732799900.SGD","IE000YTNTUN2.SGD","LU2237443622.USD","SG9999014914.USD","LU1935043536.SGD","DIPS","NVDD","BK4141","FTEC","GAMR","LU2097344357.USD","LU2322448957.HKD","BK4592","LU0345769128.USD","LU1721428933.USD","LU2148611432.USD","LU1983299246.USD","LU0494093205.USD","SGXZ81514606.USD","LU2420271590.USD","LU0823414551.USD","LU1633808545.USD","LU1093756325.SGD","ESUM","LU1720051108.HKD","IE00B1XK9C88.USD","LU0158827948.USD","TTXU","LU0795875169.SGD","IE00BZ1G4Q59.USD","LU0689626769.HKD","LU2236285917.USD","BK4184","LU2506951792.HKD","LU1989772923.USD","LU1821325948.USD","LU0820561818.USD","BK4614","LU0726765562.USD","LU0823414478.USD","LU0234572021.USD","JGRO","BK4552","IE00BBT3K403.USD","CHPX","LU1894683264.USD","LU2089284900.SGD","LU0174119429.USD","LU0225284248.USD","LU0417517546.SGD","NVD2.UK","IE00B42XCP33.USD","LU0353189763.USD","LU0256863902.USD","LU2125154935.USD","LU1066051225.USD","LU1066051811.HKD","SOXQ","IE0001KFT4U8.USD","LU1069347547.HKD","LU2272731865.HKD","BK4535","HK0000306701.USD","LU2272731782.SGD","SG9999014906.USD","BK4532","LU2249611893.SGD","IE000Q6AESB8.SGD","USD","LU0708995401.HKD","LU0203201768.USD","LU1267930573.SGD","LU2100268510.USD","IE00BVYPNW00.USD","HK0000306685.HKD","IE0034235295.USD","IE00BJJMRY28.SGD","LU2505996509.AUD","LU2361044865.SGD","LU1267930730.SGD","LU2487616109.SGD","LU0048584097.USD","LU0157215616.USD","SG9999018857.SGD","LU1066051498.USD","LU0965509101.SGD","LU1868836914.USD","LU1261432733.SGD","PRVT","LU0154236417.USD","LU2211815571.USD","SOXX","2NVD.UK","LU2452424414.USD","LU0731783048.USD","SG9999014542.SGD","IE00BJJMRX11.SGD","LU2047632596.USD","LU1791710582.SGD","SG9999015986.USD","LU0345768153.USD","LU1116320901.HKD","LU2357305700.SGD","LU1064131342.USD","LU1267930490.SGD","LU0731783394.SGD","NVYY","ANV","IE00BMPRXR70.SGD","LU2552382132.HKD","LU1951200564.SGD","LU2125909759.SGD","LU2360107168.USD","LU2023250330.USD","LU2023251221.USD","IE00B775SV38.USD","LU2413666699.HKD","FDFF","LU1400636657.SGD","LU1992135472.HKD","LU0345770308.USD","LU2191332357.HKD","KKR","IE0009356076.USD","IE00BFXG1179.USD","SG9999000418.SGD","LU0321505439.SGD","IE00BJLML261.HKD","LU2125909593.SGD","LU0070217475.USD","ILDR","LU0354030438.USD","LU2054465674.USD","IE00BK4W5M84.HKD","ESLG","LU1435385759.SGD","LU1989772840.SGD","LU1551013425.SGD","BK4550","LU0208291251.USD","LU1244550494.USD","IE00BLSP4452.SGD","LU1670627923.USD","LU1935042215.USD","TRFK","LU0006061336.USD","LU0143551892.USD","LU0345770993.USD","BK4549","LU2290526834.HKD","IE0005OL40V9.USD","NVDU","SG9999014880.SGD","LU1481011911.USD","LU1670711040.USD","LU1868837136.USD","LU0029864427.USD","IE00B3S45H60.SGD","LU0187121727.USD","LU2168564065.EUR","NVDS","LU0648001328.SGD","WISE","IE00BGHQF748.EUR","LU1127390331.HKD","LU2237443465.HKD","BK4529","HK0000320223.HKD","LU0348723411.USD","IE00B1BXHZ80.USD","LU1496350171.SGD","LU2125909916.SGD","LU0942090050.USD","LU0320765059.SGD","LU0795875086.SGD","LU2756315318.SGD","IE00B775H168.HKD","LU0310799852.SGD","LU0133085943.USD","LU2552382058.USD","METV","LU1974910355.USD","HK0000304805.HKD","NVD","BK4598","LU0985320562.USD","LU1400636491.USD","LU0109391861.USD","LBO","LU0109392836.USD","LU2999663052.SGD","LU2097344431.USD","GPZ","BK4516","LU0545039389.USD","LU1815336760.USD","LU0124676726.USD","BK4534","LU2596442595.SGD","GB00BDT5M118.USD","LU0080751232.USD","LU0266013472.USD","LU0985481810.HKD","IE00BYXW3230.USD","LU1718418525.SGD","LU0823434740.USD","LU0127658192.USD","LU0823434583.USD","LU2471134879.HKD","LU2242649171.HKD","SMH","LU2860962120.EUR","LU0210528500.USD","LU0138981039.USD","LU0210533765.USD","HK0000532082.HKD","NVDQ","SG9999015978.USD","LU0868494617.USD","LU1585245621.USD","IE00BQXX3D17.EUR","LU2543165471.USD","IE0003U64NQ7.SGD","LU0354030511.USD","LU2237443978.SGD","LU0456855351.SGD","LU1084165304.USD","CNEQ","LU2065169927.USD","LU2491050071.SGD","LU2168563687.JPY","LU1934455194.USD","LU0072462426.USD","IE00BDGV0183.EUR","LU2413666426.HKD","LU1861215975.USD","LU1668664300.SGD","SG9999018865.SGD","LU1400636574.HKD","IE00B64PRP62.GBP","LU2357125470.USD","LU2462591277.SGD","LU2092627202.USD","LU0742534661.SGD","LU1003077747.HKD","LU2087621335.USD","LU2111349929.HKD","LU2242652126.USD","LU0061474960.USD","LU0267386448.USD","LU2430703095.HKD","LU1116320737.USD","LU1551013342.USD","LU0265550946.USD","LU0314104364.USD","NVDG","LU2065171402.SGD","LU0943347566.SGD","NVDX","SG9999017495.SGD","IHE","LU1989771016.USD","IE00BSNM7G36.USD","IE00B4JS1V06.HKD","LU2237443382.USD","BK4503","BK4605","LFGY","BK4559","LU2471134952.CNY","07788","LU2023250504.SGD","SGXZ23171101.USD","LU2089283258.USD","LU0130102774.USD","LU2471134796.USD","LU2491050154.USD","TEK","LU0889565833.HKD","LU1934455863.HKD","LU2244417387.USD","NVDW","LU1917777945.USD","LU0353189680.USD","IE00B2B36J28.USD","LU1923622291.USD","LU2746668974.SGD","IXN","LU2931357623.SGD","LU1629891620.HKD","LU2250418816.HKD","LU2552382215.SGD","IE00B5TLWC47.USD","LU1880398471.USD","IE00BDRTCR15.USD","LU0251131958.USD","LU0070302665.USD","EFIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969540","title":"施贵宝将斥资23亿美元在休斯顿新建生产设施","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969540","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658969540?lang=zh_cn&edition=full","pubTime":"2026-08-11 11:41","pubTimestamp":1786419695,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0321505868.SGD","LU0061475181.USD","LU1291159041.SGD","LU1868836757.USD","LU1983299246.USD","BK4559","BK4532","LU1261432733.SGD","LU2242652126.USD","BK4588","IE00B2B36J28.USD","BMY","LU0321505439.SGD","LU1670710588.SGD","IE0002141913.USD","LU0237698245.USD","LU0985481810.HKD","LU1989771016.USD","FTXH","LU1571399168.USD","LU1323610961.USD","LU0432979614.USD","LU1868836591.USD","LU2133065610.SGD","LU1868836914.USD","LU1430594728.SGD","LU0267386448.USD","IE00BSNM7G36.USD","LU1868837300.USD","LU1032466523.USD","IE00BJT1NW94.SGD","LU2125154935.USD","IHE","LU0096364046.USD","IE00BFXG1179.USD","LU0306807586.USD","LU2360032135.SGD","LU1670711123.USD","LU2596442595.SGD","LU2125154778.USD","IE00BJJMRZ35.SGD","LU1074936037.SGD","LU1093756325.SGD","LU1868837136.USD","BK4581","LU1883839398.USD","LU0456855351.SGD","LU1093756168.USD","BK4007","LU0306806265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183112553","title":"百时美施贵宝斥资23亿美元在休斯敦建设制药基地，扩大美国制造布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1183112553","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183112553?lang=zh_cn&edition=full","pubTime":"2026-08-10 21:23","pubTimestamp":1786368216,"startTime":"0","endTime":"0","summary":" $施贵宝(BMY)$宣布，将投入约23亿美元，在美国得克萨斯州休斯敦建设一座新的制药生产基地，以扩大其美国制造能力。","market":"us","thumbnail":"https://community-static.tradeup.com/news/a1656cfd2a6cd4b8dbc594f7f4f54ed3","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/a1656cfd2a6cd4b8dbc594f7f4f54ed3"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1173574888","title":"施贵宝大手笔投入23亿美元，得州休斯顿新建美国制造园区","url":"https://stock-news.laohu8.com/highlight/detail?id=1173574888","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173574888?lang=zh_cn&edition=full","pubTime":"2026-08-10 21:03","pubTimestamp":1786367005,"startTime":"0","endTime":"0","summary":"施贵宝（Bristol Myers Squibb）正加速推进其在美国本土的制造布局，斥资23亿美元，在得克萨斯州休斯顿打造全新园区。这一举措标志着该公司在强化国内生产能力上的重大战略转折。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU2133065610.SGD","LU1868836591.USD","LU2596442595.SGD","LU0306807586.USD","LU0267386448.USD","LU0321505868.SGD","LU0432979614.USD","LU1323610961.USD","LU1670711123.USD","IHE","IE0002141913.USD","LU0882574055.USD","LU0306806265.USD","IE00B2B36J28.USD","LU0321505439.SGD","LU2242646821.SGD","LU0868494617.USD","IE00BJJMRZ35.SGD","LU1093756168.USD","LU1670711040.USD","LU1983299246.USD","FTXH","LU1571399168.USD","BK4585","LU0237698245.USD","BK4532","LU1868836757.USD","LU2125154935.USD","BK4534","LU1718418525.SGD","LU0985481810.HKD","LU1585245621.USD","LU2360032135.SGD","LU1261432733.SGD","IE0009355771.USD","BK4559","LU0061475181.USD","BK4588","LU1868837136.USD","LU1430594728.SGD","LU1670710588.SGD","LU0456855351.SGD","LU1868837300.USD","LU2125154778.USD","IE00BJT1NW94.SGD","LU0114720955.EUR","LU1074936037.SGD","LU1989771016.USD","LU1883839398.USD","LU1291159041.SGD","BK4007","LU0225284248.USD","IE00BFXG1179.USD","LU1032466523.USD","LU0096364046.USD","LU1670710661.SGD","LU0225771236.USD","IE00BSNM7G36.USD","LU1093756325.SGD","BK4581","LU2242652126.USD","BMY","LU1868836914.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bms.com","stockEarnings":[{"period":"1week","weight":0.0036},{"period":"1month","weight":0.0501},{"period":"3month","weight":0.1668},{"period":"6month","weight":0.1083},{"period":"1year","weight":0.4311},{"period":"ytd","weight":0.2388}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1294}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"百时美施贵宝公司于1933年8月在美国德拉瓦州注册成立，源自于1887年在纽约创办的企业，并在1989年因合并而重命名。作为一家生物制药公司，百时美施贵宝专注于创新药物的发现、开发、许可、生产、营销和销售，以对抗严重疾病。公司的战略方法结合了大型制药公司的资源和规模，以及生物技术行业特有的灵活性和创新重点。百时美施贵宝优先关注肿瘤学、血液学、免疫学、心血管和神经科学等领域的变革性药物，旨在提供长期价值和竞争优势。作为全球研究型制药公司，百时美施贵宝的产品在全球范围内销售，服务于包括批发商、分销商和特药药房在内的多种实体，并在多个国家保持着重要的生产运营。","yearOnYearQuotes":[{"month":1,"riseRate":0.478261,"avgChangeRate":-0.011323},{"month":2,"riseRate":0.565217,"avgChangeRate":0.011855},{"month":3,"riseRate":0.630435,"avgChangeRate":0.007963},{"month":4,"riseRate":0.468085,"avgChangeRate":-0.005808},{"month":5,"riseRate":0.553191,"avgChangeRate":0.001393},{"month":6,"riseRate":0.617021,"avgChangeRate":0.009381},{"month":7,"riseRate":0.425532,"avgChangeRate":0.001143},{"month":8,"riseRate":0.531915,"avgChangeRate":-0.000512},{"month":9,"riseRate":0.531915,"avgChangeRate":0.009722},{"month":10,"riseRate":0.586957,"avgChangeRate":0.025121},{"month":11,"riseRate":0.630435,"avgChangeRate":0.022318},{"month":12,"riseRate":0.630435,"avgChangeRate":0.022265}],"exchange":"NYSE","name":"施贵宝","nameEN":"Bristol-Myers Squibb"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"施贵宝,BMY,施贵宝股票,施贵宝股票老虎,施贵宝股票老虎国际,施贵宝行情,施贵宝股票行情,施贵宝股价,施贵宝股市,施贵宝股票价格,施贵宝股票交易,施贵宝股票购买,施贵宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}